Fatigue resident survival guide: Difference between revisions
Jump to navigation
Jump to search
TayyabaAli (talk | contribs) |
TayyabaAli (talk | contribs) |
||
Line 81: | Line 81: | ||
{{familytree | | | | | | | | | | | | | B01 | | | B01=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''The history should also determine the characteristics, severity, and temporal pattern of fatigue:'''<BR>❑ Onset – Abrupt or gradual, relationship to illness or life event <BR>❑ Course – Stable, improving, or worsening <br>❑ Duration and daily pattern<BR>❑ Factors that alleviate or exacerbate it<BR>❑ Impact on daily life – Ability to work, socialize, participate in family activities<BR>❑ Accommodations that the patient/family has had to make to deal with symptom</div>}} | {{familytree | | | | | | | | | | | | | B01 | | | B01=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''The history should also determine the characteristics, severity, and temporal pattern of fatigue:'''<BR>❑ Onset – Abrupt or gradual, relationship to illness or life event <BR>❑ Course – Stable, improving, or worsening <br>❑ Duration and daily pattern<BR>❑ Factors that alleviate or exacerbate it<BR>❑ Impact on daily life – Ability to work, socialize, participate in family activities<BR>❑ Accommodations that the patient/family has had to make to deal with symptom</div>}} | ||
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | }} | {{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | }} | ||
{{familytree | | |,|-|-|-|v|-|-|-|v|-|-| | {{familytree | | |,|-|-|-|v|-|-|-|v|-|-|!|-|-|v|-|-|-|v|-|-|-|v|-|-|-|.| }} | ||
{{familytree | | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | }} | {{familytree | | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | }} | ||
{{familytree | | F01 | | F02 | | F03 | | F04 | | F05 | | F06 | | F07| |F01=[[Bite cells|Degmacytes]]|F02=Normal cell morphology|F03=[[Spherocytes]]|F04=[[Elliptocytes]]|F05=[[Shistocytes]]|F06=Sickle shaped cells|F07= Hypochromic, microcytic cells</div>}} | {{familytree | | F01 | | F02 | | F03 | | F04 | | F05 | | F06 | | F07| |F01=[[Bite cells|Degmacytes]]|F02=Normal cell morphology|F03=[[Spherocytes]]|F04=[[Elliptocytes]]|F05=[[Shistocytes]]|F06=Sickle shaped cells|F07= Hypochromic, microcytic cells</div>}} |
Revision as of 19:08, 7 August 2020
Fatigue Resident Survival Guide |
---|
Overview |
Causes |
FIRE |
Diagnosis |
Treatment |
Do's |
Don'ts |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Tayyaba Ali, M.D.[2]
Synonyms and keywords:: Weakness, Tiredness, Lethargy, Debility
Overview
This section provides a short and straight to the point overview of the disease or symptom. The first sentence of the overview must contain the name of the disease.
Causes
Life Threatening Causes
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
Common Causes
- Infection
- Diabetes
- Hypercalcemia
- Anemia
- Rheumatologic diseases
- Neurologic injury
- Adrenal insufficiency
- Thyroid insufficiency
- Hepatic-insufficiency
- Renal insufficiency
- Cardiopulmonary diseases
- Congestive heart failure
- Chronic obstructive pulmonary disease
- Peripheral vascular disease
- Atypical angina
- Myopathy
- Medications
- Sedative-hypnotics
- Analgesics
- Antihypertensives
- Antidepressants
- Muscle relaxants
- Opioids
- Antibiotics
- Anticancer agents (like cisplatin and Etoposide)
- Substance abuse
- Psychological Causes:
- Depression
- Anxiety
- Somatization disorder
- Dysthymic disorder
- chronic fatigue syndrome
- Multiple sclerosis
- After malignancy treatment, patients can experience different patterns of fatigue from chemotherapy, radiation treatment, or surgery[1].
Diagnosis
The approach to diagnosis of fatigue is based on a step-wise testing strategy. Below is an algorithm summarising the identification and laboratory diagnosis of fatigue.
{{familytree | | | | | | | | | | | | | B01 | | | B01=Seek proper history, ask patients to describe in their own words, what do they mean by fatigue? This will help distinguish fatigue from ❑ somnolence ❑ muscle weakness | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The history should also determine the characteristics, severity, and temporal pattern of fatigue: ❑ Onset – Abrupt or gradual, relationship to illness or life event ❑ Course – Stable, improving, or worsening ❑ Duration and daily pattern ❑ Factors that alleviate or exacerbate it ❑ Impact on daily life – Ability to work, socialize, participate in family activities ❑ Accommodations that the patient/family has had to make to deal with symptom | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Degmacytes | Normal cell morphology | Spherocytes | Elliptocytes | Shistocytes | Sickle shaped cells | Hypochromic, microcytic cells | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Initial workup for hemolysis: ❑ Indirect bilirubin ❑ serum haptoglobin ❑ Lactate dehydrogenase level ❑ Reticulocyte count ❑ Urinalysis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No laboratory evidence of hemolysis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consider differential diagnosis ❑ Iron deficiency anemia ❑ Anemia of chronic disease ❑ Vitamin B12 deficiency ❑ Folate deficiency | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Degmacytes | Normal cell morphology | Spherocytes | Elliptocytes | Shistocytes | Sickle shaped cells | Hypochromic, microcytic cells | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
G6PD deficiency | Sickle cell disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
H/o exercise, exertion, trauma or surgery? | Beta thalassemia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Negative | Positive | No | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CD55/59 | ❑ Drug induced hemolytic anemia ❑ Autoimmune disease | ❑Exercise induced hemolysis ❑Prosthetic heart valve ❑Severe aortic stenosis | Microangiopathic hemolytic anemia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Positive | Negative | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pre-eclampsia and eclampsia | Recent diarrhea | Decreased ADAMTS13 activity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Paroxysmal nocturnal hemoglobinuria | Hereditary spherocytosis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
HELLP syndrome | Hemolytic uremic syndrome | Thrombotic thrombocytopenic purpura | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment
Shown below is an algorithm summarizing the treatment of [[disease name]] according the the [...] guidelines.
Do's
- The content in this section is in bullet points.
Don'ts
- The content in this section is in bullet points.
References
- ↑ Greenberg DB (2002). "Clinical Dimensions of Fatigue". Prim Care Companion J Clin Psychiatry. 4 (3): 90–93. doi:10.4088/pcc.v04n0301. PMC 181235. PMID 15014735.